Company Overview and News
KUALA LUMPUR: FGV Holdings Bhd, Marine & General Bhd, Vertice Bhd, Vizione Holdings Bhd , DBE Gurney Resources Bhd and AirAsia Group Bhd are among the stocks to watch, according to JF Apex Research.
KUALA LUMPUR (Sept 3): Based on corporate announcements and news flow today, companies that may be in focus tomorrow (Sept 4) may include the following: Lotte Chemical Titan Holding Bhd, AirAsia Group Bhd, FGV Holdings Bhd, Marine & General Bhd, HeveaBoard Bhd, Uzma Bhd, Vertice Bhd, Vizione Holdings Bhd, DBE Gurney Resources Bhd.and Supermax Corp Bhd.
FLY SPMXY 5209 SPMXF BSMAF 1818
KUALA LUMPUR (Sept 3): Marine & General Bhd (M&G) has received a one-year extension on its contract from Repsol Oil & Gas Malaysia Ltd for the provision of two anchor handling tug supply vessels.
KUALA LUMPUR (Aug 24): MMC Corp Bhd's net profit slumped 66% to RM20.08 million in the second quarter ended June 30, 2018 (2QFY18), from RM59.81 million a year ago, due largely to lower contribution from Johor Port Bhd and Northport (Malaysia) Bhd.
KUALA LUMPUR (Aug 20): Based on corporate announcements and news flow today, companies in focus on Tuesday (Aug 21) may include the following: Utusan Melayu (Malaysia) Bhd, Petrol One Resources Bhd, Eita Resources Bhd, Gadang Holdings Bhd, Dayang Enterprise Holdings Bhd, Petronas Dagangan Bhd, Allianz Malaysia Bhd, United Plantations Bhd, Eastern and Oriental Bhd (E&O), Velesto Energy Bhd, Amway (Malaysia) Holdings Bhd and Rex Industry Bhd.
9261 UPBMF 5681 5141 7027 1163 2089 5754 5209 5208 9946 BSMAF 1818
KUALA LUMPUR (Aug 20): Dayang Enterprise Holdings Bhd has secured two five-year maintenance, construction and modification contracts via its wholly-owned subsidiary Dayang Enterprise Sdn Bhd (DESB).
Gas Malaysia Bhd (Aug 9, RM2.90) Maintain buy with an unchanged target price (TP) of RM3.50: Gas Malaysia Bhd’s reported earnings in the second quarter ended June 30, 2018 (2QFY18) surged 42.4% year-on-year (y-o-y) to RM48.1 million. The company’s six months of FY18 earnings came in broadly within our and consensus expectations, making up 45% and 48% of FY18 earnings estimates, respectively. We continue to expect stronger quarters ahead as the second half is typically a stronger period for Gas Malaysia.
KUALA LUMPUR (Aug 9): Gas Malaysia Bhd rose 2.73% in early trade this morning after it reported a 42% jump in its net profit for the second quarter ended June 30, 2018 (2QFY18) to RM48.07 million from RM33.76 million in the year-ago quarter, thanks to a higher volume of natural gas sold and higher natural gas tariff.
KUALA LUMPUR: Shares in Gas Malaysia Bhd rose in early trade Thursday after its second-quarter net profit jumped 42% year-on-year.
KUALA LUMPUR: Gas Malaysia Bhd , Kelington Group Bhd , Zecon Bhd , IJM Corp Bhd and ECS ICT Bhd are among the stocks to watch on Thursday, according to JF Apex Research.
5209 5162 0151
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...